LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Buy Nvidia, Broadcom and these other underappreciated AI plays, Goldman Sachs says

Chaim Potok by Chaim Potok
July 10, 2025
in Investing
Buy Nvidia, Broadcom and these other underappreciated AI plays, Goldman Sachs says
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Goldman Sachs spotlighted a slew of artificial intelligence-related beneficiaries that it believes the market is not yet fully appreciating. Analyst James Schneider issued buy ratings on Nvidia , Broadcom , Cadence Design Systems and Synopsys . The analyst said he is most constructive on merchant and select custom silicon and electronic design automation (EDA) software vendors that are tied to ongoing AI-related spending. He predicted the inference market will see a dramatic growth uptick over the next five years led by hyperscalers and beyond. “We believe the AI investment cycle is in a state of transition, with over $350bn in CapEx spent on AI infrastructure,” he said. “Although monetization has been elusive, we see early signs of incremental revenue and much clearer evidence of cost takeout to justify these investments — and we believe AI CapEx can sustain growth from current levels.” Schneider highlighted that early signs of AI use cases — such as driving corporate headcount reductions and greater sales — have emerged and created a path towards reinvestment into future growth. As AI model training and use cases evolve, he sees a “barbell” approach to semiconductor investments emerging, which involve what he calls “performance and software ecosystem leaders” and “low-cost custom silicon leaders that drive greater affordability.” Schneider has price targets on Nvidia and Broadcom of $185 and $315, respectively. That implies upside of more than 13% for each stock. Both stocks are up around 20% for the year. Nvidia will remain the biggest beneficiary of the ongoing AI infrastructure buildout, Schneider said. He’s optimistic on the company’s broadening customer base, product leadership and rapid new releases as well as its attractive valuation that he thinks can drive stock outperformance in the medium term. Chipmaker Broadcom should drive outsized market share in custom silicon for hyperscalers, Schneider said. “Broadcom also continues to generate steady, growing profitability in its infrastructure software business,” Schneider said, adding that AI will likely comprise over 40% of the company’s revenue by 2026. “We see the stock’s premium valuation as justified by the visibility provided by sole-sourcing at silicon accounts and the mission-critical nature of its software portfolio.” Schneider also likes Cadence, which makes software and hardware for chip design. He called the company a high-quality compounding business with multiple growth drivers. Year to date, shares are up 7%. Goldman’s $380 price target on the stock signals upside of 17.7%. Synopsys, another chip design stock Schneider likes, is up more than 13% in 2025. “We see long-term growth driven by the diffusion of custom chip design across a broader range of customers with an outsized need for IP, although we acknowledge ongoing potential headline risk from China export restrictions,” he said. Goldman’s $620 price target on Synopsys points to a gain of 12.5%.



Source link

You might also like

Supreme Court says Trump’s tariffs aren’t legal. These stocks should benefit most

Student loan delinquency rate jumps to nearly 25% in Trump’s second term, analysis finds

What Supreme Court ruling against Trump tariffs means for your money

Share30Tweet19
Previous Post

Trade strategy must support smaller exporters  – London Business News | London Wallet

Next Post

xAI teases Grok upgrades, Musk says AI could discover new physics

Chaim Potok

Chaim Potok

Recommended For You

Supreme Court says Trump’s tariffs aren’t legal. These stocks should benefit most
Investing

Supreme Court says Trump’s tariffs aren’t legal. These stocks should benefit most

February 20, 2026
Student loan delinquency rate jumps to nearly 25% in Trump’s second term, analysis finds
Investing

Student loan delinquency rate jumps to nearly 25% in Trump’s second term, analysis finds

February 20, 2026
What Supreme Court ruling against Trump tariffs means for your money
Investing

What Supreme Court ruling against Trump tariffs means for your money

February 20, 2026
The Dow is just below 50,000. How to trade a move above the key level using options
Investing

The Dow is just below 50,000. How to trade a move above the key level using options

February 20, 2026
Next Post
xAI teases Grok upgrades, Musk says AI could discover new physics

xAI teases Grok upgrades, Musk says AI could discover new physics

Related News

Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccine

Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccine

October 26, 2023
How to prevent AI from ‘annihilating humanity’ using blockchain – Cointelegraph Magazine

How to prevent AI from ‘annihilating humanity’ using blockchain – Cointelegraph Magazine

January 19, 2023
Immutable delays M token vesting by another year

Immutable delays $67M token vesting by another year

October 17, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?